Sliwka, A., Jankowski, M., Gross‐Sondej, I., Storman, M., Nowobilski, R., & Bala, M. M. (2018). Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev.
Stile di citazione ChicagoSliwka, Agnieszka, Milosz Jankowski, Iwona Gross‐Sondej, Monika Storman, Roman Nowobilski, e Malgorzata M. Bala. "Once‐daily Long‐acting Beta₂‐agonists/inhaled Corticosteroids Combined Inhalers Versus Inhaled Long‐acting Muscarinic Antagonists for People With Chronic Obstructive Pulmonary Disease." Cochrane Database Syst Rev 2018.
Citazione MLASliwka, Agnieszka, et al. "Once‐daily Long‐acting Beta₂‐agonists/inhaled Corticosteroids Combined Inhalers Versus Inhaled Long‐acting Muscarinic Antagonists for People With Chronic Obstructive Pulmonary Disease." Cochrane Database Syst Rev 2018.